B2bmart360India's largest online marketplace, B2bmart 360 connects manufacturers, exporters, distributors & suppliers for seamless trade. Reliable, transparent platformhttps://www.b2bmart360.com/s/645a2cfc40fed60b90247247/66066d164cf03f27fbe4f178/b2bmart360-logo-480x480.jpeg
Unit No. 458, Plot No. E-5, Aggarwal Metro Height NSP, Pitampura-110034IN
B2bmart360
Unit No. 458, Plot No. E-5, Aggarwal Metro Height NSP, Pitampura, IN
+918375098857https://www.b2bmart360.com/s/645a2cfc40fed60b90247247/66066d164cf03f27fbe4f178/b2bmart360-logo-480x480.jpeg"[email protected]
662b4bbd93c02534636f254eBalversa ErdafitinibBalversa Erdafitinib
1
BOX
Minimum Order Quantity1 Box
Composition: Erdanib-4: Each film coated tablet contains Erdafitinib INN 4.00 mg. Erdanib-5: Each film coated tablet contains Erdafitinib INN 5.00 mg. Pharmacology: Erdafitinib is a kinase inhibitor that binds to and inhibits enzymatic activity of FGFR1, FGFR2, FGFR3 and FGFR4 based on in vitro data. Erdafitinib also binds to RET, CSF1R, PDGFRA, PDGFRB, FLT4, KIT, and VEGFR2. Erdafitinib inhibited FGFR phosphorylation and signaling and decreased cell viability in cell lines expressing FGFR genetic alterations, including point mutations, amplification, and fusions. Erdafitinib demonstrated antitumor
SKU-R4HD3QAWS9S5
INR30000In Stock
11

Balversa Erdafitinib

Related Products